OLGA KULBATSKAYA: Open Payments
NPI 1861983157 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 10 payments from 7 companies in 2025. Trend: 2023 $1,125 · 2024 $931 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $259 |
| Averitas Pharma Inc. | 2 | $238 |
| Lundbeck LLC | 2 | $172 |
| AstraZeneca Pharmaceuticals LP | 1 | $127 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Novo Nordisk Inc | 1 | $112 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
Products named: REXULTI, TEZSPIRE, QUTENZA, WAINUA, Auvelity, Ozempic.
Industry payments across MO — which companies pay providers there.
